When Should I Have My PSA Levels Tested? The first thing to do is to talk to your doctor about the pros and cons of prostate cancer screening before you decide whether to be tested. Don’t get tested until you have that talk. Opinions differ about when you should do that. ...
PSA levels appear to be more predictive of three year risk in African-American men compared with Caucasian men with a family history of , according to a paper published in Cancer Prevention Research, a journal of the American Association for Cancer Research.Cancer Prevention Research...
The researchers found that PSA levels are lower in men with prostate cancer than those who have undergone operations but did not have cancer. They also insisted that the PSA is produced by benign prostatic hype...
PSA testing has revolutionized our ability to diagnose, treat, and follow-up patients. The present study evaluated PSA levels in recently diagnosed prostate cancer cases in screening. PSA was estimated by enzyme immunochemical assay in 128 patients. The study concluded that early diagnosis of ...
The article questions in utility of a prostate biopsy in men with elevated prostate-specific antigen (PSA) levels. PSA testing is acknowledged to have been instrumental in increasing prostate cancer survival rates and is a good predictor for prostate cancer. The article notes, however, that there...
If your total PSA levels are in the borderline area between 4-10 ng/mL, your free PSA ratio can give you a more detailed picture of your cancer risk. The chances that a needle biopsy will turn up prostate cancer varies by your free PSA concentration and your age: Concentration of more ...
Prevalence of Prostate Cancer Among Men with Normal PSA LevelsProstate CancerNew England Journal of Medicine
We found that in combination with free PSA ≤21% the following PSA cut-offs had the best cancer specificity: 1.75 ng/ml for men ≤49 years and 50-59 years, 2.25 ng/ml for men aged 60-69 years and 3.25 ng/ml for men ≥70 years. Using these adjusted PSA cut-off values all ...
A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient's long-term overall survival. ...
Also, a significant correlation was observed between serum PSA level and the grade of the disease.Conclusion: Considering that prostatic carcinoma is one of cancers usually diagnosed late and since biopsy is hardly accepted by patients, with regard to the relationship between serum levels of free ...